Smart insulin pump could ease diabetes after pancreas surgery

NCT ID NCT07430293

Recruiting now Disease control Sponsor: Centre Hospitalier Sud Francilien Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a hybrid closed-loop insulin pump (MiniMed 780) can help people with diabetes after pancreas removal achieve better blood sugar control. About 24 adults will use the pump for 3 months and then their usual treatment for 3 months, with results compared. The goal is to see if the automated system increases time blood sugar stays in a healthy range and improves quality of life.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATECTOMY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus post-surgical hypoinsulinemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PANCREATECTOMY PARTIAL PANCREATECTOMY TOTAL PANCREATECTOMY

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Centre Hospitalier Sud Francilien
RECRUITING

Corbeil-Essonnes, France, 91100, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact
Hôpital Bichat (APHP)
NOT_YET_RECRUITING

Paris, France, 75018, France

Contact Phone: •••-•••-•••• Email: •••••@•••••